(Q44655404)

English

Dissociation of putative graft‐versus‐haematopoiesis and graft‐versus‐myeloma effects in patients with rapidly progressive multiple myeloma*

scientific article published on November 1, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dissociation of putative graft‐versus‐haematopoiesis and graft‐versus‐myeloma effects in patients with rapidly progressive multiple myeloma* (English)

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

0 references

Hartmut Goldschmidt

3

object named as

Hartmut Goldschmidt

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Thomas Luft

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Marion Moos

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Martin Görner

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Anthony D. Ho

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616968

1 April 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2003.04670.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14616968

1 April 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04670.x

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04670.x

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

646-653

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

2

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

5

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

6

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine

10

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

12

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Aplastic anaemia: management

14

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

16

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

18

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

21

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

22

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

25

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Bone-marrow transplantation (first of two parts).

26

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Graft-versus-myeloma effect in two cases

29

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

30

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation

31

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Hematopoietic responses to stress conditions in young dogs compared with elderly dogs

32

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required

33

1 reference

10.1046/J.1365-2141.2003.04670.X

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04670.X

1 April 2024

Identifiers

10.1046/J.1365-2141.2003.04670.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44655404&oldid=2118757040"